Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Arca Biopharma Inc (ABIO)

5.95   -0.01 (-0.17%) 08-14 16:00
Open: 5.9 Pre. Close: 5.96
High: 6.05 Low: 5.9
Volume: 379,431 Market Cap: 35M
ARCA biopharma, Inc. operates as a biopharmaceutical company applying a precision medicine approach to developing and commercializing genetically targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride) is pharmacogenetically-targeted beta-adrenergic receptor antagonist, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of AB171, a thiol-substituted isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.09 - 6.148 6.148 - 6.183
Low: 5.775 - 5.852 5.852 - 5.898
Close: 5.862 - 5.987 5.987 - 6.062

Technical analysis

as of: 2020-08-14 4:26:57 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 8.83     One year: 10.06
Support: Support1: 5.86    Support2: 4.88
Resistance: Resistance1: 7.56    Resistance2: 8.61
Pivot: 6.71
Moving Average: MA(5): 6.36     MA(20): 6.85
MA(100): 5.73     MA(250): 5.38
MACD: MACD(12,26): -0.17     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 7.45     %D(3): 16.01
RSI: RSI(14): 37.45
52-week: High: 22.00  Low: 2.21  Change(%): 13.3
Average Vol(K): 3-Month: 231166  10-Days: 108660

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ABIO has closed below the lower band by 4.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 60.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ABIO's normal range. The bands have been in this narrow range for 36 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 13 Aug 2020
Should You Buy Arca Biopharma Inc (ABIO) Stock? - InvestorsObserver

Thu, 13 Aug 2020
ARCA biopharma, Inc. (ABIO) and the Battle of Fundamental vs. Technical - The News Heater

Wed, 12 Aug 2020
ARCA biopharma Inc. (ABIO) is set to bring smile on the investors face as Analysts sets mean Target price of $7.00 - The InvestChronicle

Wed, 12 Aug 2020
ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19 - Yahoo Finance

Mon, 10 Aug 2020
ARCA biopharma Inc. (ABIO) 14-day ATR is 0.50: This Stock is Set to Soar Above its Peers - News Daemon

Wed, 05 Aug 2020
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 4
Shares Float (M) 1
% Held by Insiders 0.57
% Held by Institutions 13.28
Shares Short (K) 25
Shares Short P. Month (K) 8

Stock Financials

EPS -3.430
EPS Est This Year -1.750
EPS Est Next Year -1.190
Book Value (p.s.) 3.960
Profit Margin
Operating Margin
Return on Assets (ttm) -41.8
Return on Equity (ttm) -75.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.196
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M) -3

Stock Valuations

PE Ratio -1.73
PEG Ratio
Price to Book value 1.50
Price to Sales
Price to Cash Flow -5.42

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.